光線療法装置市場規模、シェア、動向、2031年までの世界予測

光線療法機器市場は、2026年の4億7000万米ドルから2031年には6億2000万米ドルに成長し、年平均成長率は5.5%に達するとMarketsandMarketsでは予測しています。

継続的な技術革新、特に従来の蛍光灯やハロゲン光源からLEDベースの光線療法システムへの移行は、市場の成長を大きく牽引しています。LED光線療法装置は、エネルギー効率の向上、動作寿命の延長、発熱量の低減、精密な波長制御など、多くの利点を提供し、治療効果を高めながらリスクを最小限に抑えます。これらのシステムは均一な光分布も実現し、新生児および皮膚科領域の両方で臨床結果を改善します。さらに、装置設計の進歩により、コンパクトで使いやすく、メンテナンスの手間がかからないシステムが開発され、様々なリソースレベルの医療施設でも利用しやすくなっています。メーカーは、デジタルディスプレイ、強度制御、自動タイマーなどのスマート機能も統合しており、使いやすさと治療精度を向上させています。医療従事者の間で技術的に高度なソリューションへの嗜好が高まっていることから、旧型機器の最新LEDベースシステムへの置き換えが加速しています。この継続的なイノベーションサイクルは、患者の治療結果を改善するだけでなく、アップグレードされた光線療法装置に対する世界的な需要を安定的に生み出しています。

調査概要

本レポートは、光線療法機器市場を評価し、製品、用途、エンドユーザー、地域といった様々なセグメントに基づいて、市場規模と将来の成長可能性を予測します。また、主要企業の競合分析に加え、企業プロファイル、製品ラインナップ、最新動向、主要な市場戦略についても詳述しています。

本レポートを購入する理由

本レポートは、市場リーダー企業および新規参入企業に対し、市場全体、光線療法機器市場、およびそのサブセグメントにおける収益の近似値に関するデータを提供します。また、関係者が競争環境を理解し、より的確な市場戦略を策定するための洞察を得るのに役立ちます。さらに、市場の動向を把握し、市場における影響力のある推進要因、阻害要因、障害、機会に関するデータを提供します。

本レポートは、以下の点について考察します。

主要な推進要因（新生児黄疸の発生率上昇、早産児および低出生体重児の増加、皮膚疾患の罹患率上昇、先進的な光線療法機器の発売、LED光線療法機器の普及拡大）、阻害要因（代替治療法の普及拡大、新規機器承認に関するFDAの厳格な規制）、機会（低コスト光線療法機器の開発、皮膚疾患治療における家庭用光線療法の普及拡大）、および課題（新興市場における再生光線療法機器購入の増加傾向、発展途上国における光線療法機器の普及の遅れ）の分析。

• 製品の強化／イノベーション：世界の光線療法機器市場における製品発売と予測されるトレンドに関する包括的な詳細情報。
• 市場開発：製品、用途、エンドユーザー、地域別の収益性の高い成長市場に関する徹底的な知識と分析。
• 市場の多様化：世界の光線療法機器市場における新製品、拡大市場、最新の技術進歩、投資に関する包括的な情報
• 競合評価：世界の光線療法機器市場における主要競合企業の市場シェア、成長戦略、製品・サービス、生産能力を徹底的に評価

Report Description

The phototherapy equipment market is projected to reach USD 0.62 billion by 2031, up from USD 0.47 billion in 2026, at a CAGR of 5.5%.

Continuous technological innovation, particularly the transition from conventional fluorescent and halogen light sources to LED-based phototherapy systems, is significantly driving market growth. LED phototherapy devices offer multiple advantages, including higher energy efficiency, longer operational lifespan, reduced heat emission, and precise wavelength targeting, which enhances treatment effectiveness while minimizing risks. These systems also provide uniform light distribution, improving clinical outcomes in both neonatal and dermatological applications. Additionally, advancements in device design have led to the development of compact, user-friendly, and low-maintenance systems, making them more accessible to healthcare facilities with varying resource levels. Manufacturers are also integrating smart features such as digital displays, intensity controls, and automated timers, which improve usability and treatment accuracy. The growing preference for technologically advanced solutions among healthcare providers is accelerating the replacement of older equipment with modern LED-based systems. This ongoing innovation cycle not only improves patient outcomes but also creates a steady global demand for upgraded phototherapy equipment.

Based on product: One of the most significant drivers of the dominance of conventional phototherapy equipment is its cost advantage over advanced alternatives, such as LED-based and fiber-optic systems. Conventional units typically have lower upfront acquisition costs, making them highly attractive for hospitals operating under tight budget constraints. In addition to capital expenditure, these systems also incur lower maintenance and servicing costs due to their simpler design and readily available components. This affordability becomes particularly crucial in price-sensitive markets, where healthcare providers must balance quality care with financial limitations. Public hospitals, small clinics, and rural healthcare centers often prioritize cost-effective solutions that can deliver acceptable clinical outcomes without significant investment. Moreover, large-scale procurement programs, especially in government-funded healthcare systems, tend to favor conventional equipment due to its economic viability. This strong cost-benefit equation ensures that conventional phototherapy remains widely accessible and continues to dominate market demand despite the availability of technologically advanced alternatives.

Based on application: Phototherapy is universally recognized as the first-line treatment for neonatal hyperbilirubinemia due to its proven safety, efficacy, and non-invasive nature. It works by converting bilirubin into water-soluble isomers that can be excreted without requiring liver conjugation. Clinical guidelines across major health organizations strongly recommend phototherapy as the initial intervention before considering more invasive procedures such as exchange transfusion. This strong clinical endorsement ensures that phototherapy devices are routinely used in hospitals, particularly in NICUs and maternity centers. The treatment is easy to administer, requires minimal training, and has a low risk of adverse effects, making it suitable for widespread use even in resource-limited settings. Additionally, advancements such as LED-based phototherapy systems have further improved treatment efficiency and reduced operational costs, reinforcing its position as the preferred treatment modality. As a result, healthcare providers consistently rely on phototherapy equipment, which drives its dominant share in the neonatal jaundice segment.

North America’s well-developed healthcare infrastructure plays a crucial role in supporting the widespread adoption of phototherapy equipment. The region boasts an extensive network of hospitals, specialty clinics, and advanced neonatal care facilities, all equipped to diagnose and treat neonatal and dermatological conditions efficiently. Healthcare systems in the US and Canada are characterized by strong clinical protocols, modern medical technologies, and highly trained professionals, enabling seamless integration of phototherapy solutions into routine care. Additionally, the availability of well-equipped neonatal intensive care units ensures that even high-risk infants receive immediate treatment. This infrastructure not only facilitates access to phototherapy but also encourages healthcare providers to invest in technologically advanced systems such as LED-based devices. Furthermore, regular upgrades and maintenance of medical equipment, driven by stringent quality standards, contribute to sustained demand. The presence of such a robust healthcare ecosystem ensures consistent utilization and adoption of phototherapy devices across multiple care settings.

A breakdown of the primary participants (supply-side) for the phototherapy equipment market referred to in this report is provided below:

• By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the phototherapy equipment market are market Drägerwerk AG & Co. KGaA (Germany), GE HealthCare (US), Natus Medical (US), Atom Medical (Japan), Bistos (South Korea), Ningbo David (China), Phothera (US), STRATA Skin Sciences (US), Xuzhou Kernel Medical (China), Shanghai SIGMA High-tech (China), Ultralite Enterprises, Inc. (US), Hoenle Medical GmbH (Germany), Weyer (Germany), Neolight (US), Fanem (Brazil), Phoenix Medical Systems (India), among others.

Research Coverage

The report evaluates the phototherapy equipment market and estimates the market size and future growth potential of this market based on various segments, including product, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader and new entrants with data on the nearest approximations of revenue for the overall market, the phototherapy equipment market, and its subsegments. The report will assist stakeholders in understanding the competitive landscape and in gaining further insights to better position their businesses and develop appropriate go-to-market strategies.  The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

Analysis of key drivers (rising incidence of neonatal jaundice, rising number of preterm and low-weight births, rising prevalence of skin diseases, launch of technologically advanced phototherapy equipment, rising adoption of LED-based phototherapy equipment), restraints (high use of alternative modes of treatment, stringent FDA regulatory policies for the approval of new devices), opportunities (development of low-cost phototherapy equipment, rising adoption of home phototherapy for the treatment of skin diseases), and challenges (rising trend of purchasing refurbished phototherapy equipment in emerging markets, limited adoption of phototherapy equipment in developing nations)

• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global phototherapy equipment market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global phototherapy equipment market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global phototherapy equipment market

Table of Contents

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 INCLUSIONS & EXCLUSIONS 24
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 25
1.4 STAKEHOLDERS 26
1.5 SUMMARY OF CHANGES 26
2 EXECUTIVE SUMMARY 27
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 27
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 29
2.3 DISRUPTIVE TRENDS SHAPING MARKET 30
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 31
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 32
3 PREMIUM INSIGHTS 33
3.1 PHOTOTHERAPY EQUIPMENTS MARKET OVERVIEW 33
3.2 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER 34
3.3 PHOTOTHERAPY EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
3.4 PHOTOTHERAPY EQUIPMENT MARKET: REGIONAL MIX 35
3.5 PHOTOTHERAPY EQUIPMENT MARKET: DEVELOPED COUNTRIES VS.
EMERGING ECONOMIES 36
4 MARKET OVERVIEW 37
4.1 INTRODUCTION 37
4.2 MARKET DYNAMICS 37
4.2.1 DRIVERS 38
4.2.1.1 Rising incidence of neonatal jaundice 38
4.2.1.2 Growing number of preterm and low-weight births 38
4.2.1.3 Rising prevalence of skin diseases 39
4.2.1.4 Launch of technologically advanced phototherapy equipment 40
4.2.1.5 Rising adoption of LED-based phototherapy equipment 40
4.2.2 RESTRAINTS 41
4.2.2.1 High use of alternative modes of treatment 41
4.2.2.2 Stringent regulatory policies for new device approval 42

4.2.3 OPPORTUNITIES 42
4.2.3.1 Development of low-cost phototherapy equipment 42
4.2.3.2 Rising adoption of home phototherapy for treating skin diseases 43
4.2.4 CHALLENGES 44
4.2.4.1 Rising trend of purchasing refurbished equipment in emerging markets 44
4.2.4.2 Limited adoption of phototherapy equipment in developing nations 44
4.3 UNMET NEEDS AND WHITE SPACES 45
4.3.1 UNMET NEEDS IN PHOTOTHERAPY EQUIPMENT MARKET 45
4.3.2 WHITE SPACE OPPORTUNITIES 45
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 46
4.4.1 INTERCONNECTED MARKETS 46
4.4.2 CROSS-SECTOR OPPORTUNITIES 46
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 47
5 INDUSTRY TRENDS 48
5.1 PORTER’S FIVE FORCES ANALYSIS 48
5.1.1 THREAT OF NEW ENTRANTS 49
5.1.2 THREAT OF SUBSTITUTES 49
5.1.3 BARGAINING POWER OF BUYERS 50
5.1.4 BARGAINING POWER OF SUPPLIERS 50
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 50
5.2 MACROECONOMIC OUTLOOK 50
5.2.1 INTRODUCTION 50
5.2.2 GDP TRENDS AND FORECAST 51
5.2.3 TRENDS IN GLOBAL NEONATAL & DERMATOLOGY CARE INDUSTRY 53
5.3 SUPPLY CHAIN ANALYSIS 53
5.4 VALUE CHAIN ANALYSIS 55
5.5 ECOSYSTEM ANALYSIS 56
5.6 PRICING ANALYSIS 57
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2025) 57
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2024–2026) 58
5.7 TRADE ANALYSIS 59
5.7.1 IMPORT SCENARIO (HS CODE 9018090) 59
5.7.2 EXPORT SCENARIO (HS CODE 9018090) 60
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 60
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
5.10 INVESTMENT & FUNDING SCENARIO 62
5.11 CASE STUDY ANALYSIS 63
5.11.1 CASE STUDY 1: SMART NICU UPGRADE AT BOSTON CHILDREN’S HOSPITAL 63
5.11.2 CASE STUDY 2: AFFORDABLE PHOTOTHERAPY EXPANSION IN RURAL INDIA 63
5.11.3 CASE STUDY 3: PREDICTIVE NEONATAL MONITORING AT MOUNT SINAI HOSPITAL, CANADA 63
5.12 IMPACT OF US TARIFFS—PHOTOTHERAPY EQUIPMENT MARKET 63
5.12.1 INTRODUCTION 63
5.12.2 KEY TARIFF RATES 64
5.12.3 PRICE IMPACT ANALYSIS 65
5.12.4 IMPACT ON COUNTRIES/REGIONS 65
5.12.4.1 North America 65
5.12.4.2 Europe 66
5.12.4.3 Asia Pacific 66
5.12.5 END-USE INDUSTRY IMPACT 66
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 67
6.1 KEY EMERGING TECHNOLOGIES 67
6.1.1 ADVANCED LED PHOTOTHERAPY SYSTEMS 67
6.1.2 FIBER-OPTIC & WEARABLE PHOTOTHERAPY TECHNOLOGIES 67
6.2 COMPLEMENTARY TECHNOLOGIES 67
6.2.1 BIOSENSOR & CHEMICAL SENSOR TECHNOLOGIES 68
6.2.2 POINT-OF-CARE & HOME CARE TREATMENT PLATFORMS 68
6.3 TECHNOLOGY/PRODUCT ROADMAP 68
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 68
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 69
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 69
6.4 PATENT ANALYSIS 70
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 71
6.5 FUTURE APPLICATIONS 72
6.5.1 AI-ENABLED SMART PHOTOTHERAPY & CONNECTED CARE SYSTEMS 72
6.5.2 NON-INVASIVE MEDICAL BREATH DIAGNOSTICS 73
6.5.3 NEXT-GENERATION LED & PRECISION PHOTOTHERAPY TECHNOLOGIES 73
6.6 IMPACT OF AI/GEN AI ON PHOTOTHERAPY EQUIPMENT MARKET 73
6.6.1 TOP USE CASES AND MARKET POTENTIAL 74
6.6.2 BEST PRACTICES FOLLOWED BY MANUFACTURERS/OEMS IN PHOTOTHERAPY EQUIPMENT MARKET 74
6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN PHOTOTHERAPY EQUIPMENT 75
6.6.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 76
6.6.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHOTOTHERAPY EQUIPMENT MARKET 77

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 78
7.1 DECISION-MAKING PROCESS 78
7.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 78
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
7.2.2 KEY BUYING CRITERIA 79
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 80
7.4 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES 81
7.5 MARKET PROFITABILITY 81
7.5.1 REVENUE POTENTIAL 82
7.5.2 COST DYNAMICS 82
7.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 82
8 REGULATORY LANDSCAPE 83
8.1 REGIONAL REGULATIONS AND COMPLIANCE 83
8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
8.1.2 INDUSTRY STANDARDS 85
9 PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT 86
9.1 INTRODUCTION 87
9.2 CONVENTIONAL PHOTOTHERAPY 87
9.2.1 AFFORDABILITY AND ACCESSIBILITY DRIVING CONTINUED USE OF CONVENTIONAL PHOTOTHERAPY EQUIPMENT 87
9.3 FIBER-OPTIC PHOTOTHERAPY 89
9.3.1 PARENT-FRIENDLY DESIGN AND HOME-BASED CARE DEMAND ACCELERATE GROWTH IN FIBER-OPTIC PHOTOTHERAPY 89
10 PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION 92
10.1 INTRODUCTION 93
10.2 NEONATAL JAUNDICE 93
10.2.1 INCREASING NUMBER OF PRETERM AND LOW-WEIGHT BIRTHS TO DRIVE MARKET GROWTH 93
10.3 SKIN DISEASES 94
10.3.1 PSORIASIS 96
10.3.1.1 Rising demand for non-invasive therapies and technological advancements to drive market 96
10.3.2 VITILIGO 97
10.3.2.1 High effectiveness in managing vitiligo drives market growth 97
10.3.3 ECZEMA 99
10.3.3.1 Growing burden of pediatric eczema to support demand for phototherapy 99

11 PHOTOTHERAPY EQUIPMENT MARKET, BY END USER 101
11.1 INTRODUCTION 102
11.2 HOSPITALS 102
11.2.1 RISING PATIENT ADMISSIONS AND ADVANCED TREATMENT INFRASTRUCTURE SUPPORT DOMINANCE OF HOSPITALS 102
11.3 HOME CARE SETTINGS 103
11.3.1 INCREASING ADOPTION OF PORTABLE AND HOME-USE DEVICES TO DRIVE MARKET GROWTH 103
12 PHOTOTHERAPY EQUIPMENT MARKET, BY REGION 105
12.1 INTRODUCTION 106
12.2 NORTH AMERICA 107
12.2.1 US 109
12.2.1.1 Government initiatives and technological advancements supporting market growth 109
12.2.2 CANADA 111
12.2.2.1 Expansion of neonatal care services and home-based phototherapy adoption driving market growth 111
12.3 EUROPE 113
12.3.1 GERMANY 115
12.3.1.1 Advanced healthcare infrastructure and innovation leadership driving market growth 115
12.3.2 UK 117
12.3.2.1 NHS modernization and increasing dermatology treatment demand supporting market growth 117
12.3.3 FRANCE 119
12.3.3.1 Public healthcare investments and rising neonatal care demand driving market growth 119
12.3.4 ITALY 121
12.3.4.1 Healthcare modernization and rising awareness of skin disease treatments supporting market growth 121
12.3.5 SPAIN 123
12.3.5.1 Rising neonatal healthcare investments and dermatology treatment adoption are driving growth 123
12.3.6 REST OF EUROPE 125
12.4 ASIA PACIFIC 127
12.4.1 CHINA 130
12.4.1.1 Healthcare expansion and domestic medical device manufacturing driving market growth 130
12.4.2 JAPAN 131
12.4.2.1 Aging population and advanced healthcare technologies supporting market growth 131
12.4.3 INDIA 133
12.4.3.1 Rising neonatal healthcare demand and government healthcare initiatives driving market growth 133
12.4.4 AUSTRALIA 135
12.4.4.1 Expansion of neonatal healthcare programs and dermatology services supporting market growth 135
12.4.5 SOUTH KOREA 137
12.4.5.1 Technological innovation and expanding dermatology care driving market growth 137
12.4.6 REST OF ASIA PACIFIC 139
12.5 LATIN AMERICA 141
12.5.1 BRAZIL 143
12.5.1.1 Expanding neonatal healthcare services and growing dermatology market supporting growth 143
12.5.2 MEXICO 145
12.5.2.1 Healthcare modernization and increasing neonatal care awareness driving market growth 145
12.5.3 REST OF LATIN AMERICA 147
12.6 MIDDLE EAST & AFRICA 149
12.7 GCC COUNTRIES 150
13 COMPETITIVE LANDSCAPE 153
13.1 OVERVIEW 153
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 153
13.3 REVENUE ANALYSIS 155
13.4 MARKET SHARE ANALYSIS 156
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 157
13.5.1 STARS 157
13.5.2 EMERGING LEADERS 157
13.5.3 PERVASIVE PLAYERS 158
13.5.4 PARTICIPANTS 158
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 159
13.5.5.1 Company footprint 159
13.5.5.2 Region footprint 160
13.5.5.3 Product footprint 160
13.5.5.4 Application footprint 161
13.5.5.5 End-user footprint 161
13.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 162
13.6.1 PROGRESSIVE COMPANIES 162
13.6.2 RESPONSIVE COMPANIES 162
13.6.3 DYNAMIC COMPANIES 162
13.6.4 STARTING BLOCKS 162
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 164
13.6.5.1 Detailed list of key startups/SMEs 164
13.6.5.2 Competitive benchmarking of startups/SMEs 165

13.7 COMPANY VALUATION AND FINANCIAL METRICS 166
13.7.1 FINANCIAL METRICS 166
13.7.2 COMPANY VALUATION 166
13.8 BRAND COMPARISON 167
13.9 COMPETITIVE SCENARIO 168
13.9.1 PRODUCT LAUNCHES & APPROVALS 168
13.9.2 DEALS 169
14 COMPANY PROFILES 171
14.1 KEY PLAYERS 171
14.1.1 GE HEALTHCARE 171
14.1.1.1 Business overview 171
14.1.1.2 Products offered 172
14.1.1.3 MnM view 173
14.1.1.3.1 Right to win 173
14.1.1.3.2 Strategic choices 173
14.1.1.3.3 Weaknesses and competitive threats 173
14.1.2 DRÄGERWERK AG & CO. KGAA 174
14.1.2.1 Business overview 174
14.1.2.2 Products offered 175
14.1.2.3 Recent developments 176
14.1.2.3.1 Product launches 176
14.1.2.4 MnM view 176
14.1.2.4.1 Right to win 176
14.1.2.4.2 Strategic choices 176
14.1.2.4.3 Weaknesses and competitive threats 176
14.1.3 NATUS SENSORY 177
14.1.3.1 Business overview 177
14.1.3.2 Products offered 177
14.1.3.3 Recent developments 178
14.1.3.3.1 Deals 178
14.1.3.4 MnM view 179
14.1.3.4.1 Key strengths/Right to win 179
14.1.3.4.2 Strategic choices made 179
14.1.3.4.3 Weaknesses and competitive threats 179
14.1.4 PHOTHERA 180
14.1.4.1 Business overview 180
14.1.4.2 Products offered 180
14.1.4.3 Recent developments 182
14.1.4.3.1 Product launches 182
14.1.4.4 MnM view 182
14.1.4.4.1 Key strengths/Right to win 182
14.1.4.4.2 Strategic choices made 182
14.1.4.4.3 Weaknesses and competitive threats 183
14.1.5 SHANGHAI SIGMA HIGH-TECH CO., LTD. 184
14.1.5.1 Business overview 184
14.1.5.2 Products offered 184
14.1.5.3 Recent developments 185
14.1.5.3.1 Product launches 185
14.1.5.4 MnM view 186
14.1.5.4.1 Right to win 186
14.1.5.4.2 Strategic choices 186
14.1.5.4.3 Weaknesses and competitive threats 187
14.1.6 ATOM MEDICAL CORP 188
14.1.6.1 Business overview 188
14.1.6.2 Products offered 188
14.1.7 PHOENIX MEDICAL SYSTEMS 189
14.1.7.1 Business overview 189
14.1.7.2 Products offered 189
14.1.8 NEOLIGHT LLC 190
14.1.8.1 Business overview 190
14.1.8.2 Products offered 190
14.1.8.3 Recent developments 191
14.1.8.3.1 Deals 191
14.1.9 FANEM 192
14.1.9.1 Business overview 192
14.1.9.2 Products offered 193
14.1.10 BISTOS CO., LTD. 194
14.1.10.1 Business overview 194
14.1.10.2 Products offered 194
14.2 OTHER PLAYERS 195
14.2.1 NINGBO DAVID MEDICAL DEVICE CO., LTD. 195
14.2.2 STRATA SKIN SCIENCES 196
14.2.3 XUZHOU KERNEL MEDICAL EQUIPMENT CO., LTD. 197
14.2.4 ULTRALITE ENTERPRISES, INC. 198
14.2.5 HOENLE MEDICAL GMBH 199
14.2.6 WEYER GMBH 199
14.2.7 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD. 200
14.2.8 THERALIGHT, LLC 201
14.2.9 ATHRODAX LTD 202
14.2.10 CURELIGHT 203
14.2.11 PHOTO THERAPEUTICS LTD 204
14.2.12 TINY HEARTS TECHNOLOGY 205
14.2.13 LIFETRONS INNO EQUIPMENTS PVT LTD 205
14.2.14 IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT LTD 206
14.2.15 SCI HEALTH 207
15 RESEARCH METHODOLOGY 208
15.1 RESEARCH DATA 208
15.1.1 SECONDARY DATA 209
15.1.1.1 Key data from secondary sources 210
15.1.2 PRIMARY DATA 210
15.1.2.1 Key data from primary sources 211
15.1.2.2 Key industry insights 212
15.2 MARKET SIZE ESTIMATION 214
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION 219
15.4 MARKET SHARE ESTIMATION 220
15.5 STUDY ASSUMPTIONS 220
15.6 METHODOLOGY-RELATED LIMITATIONS 220
15.7 RISK ASSESSMENT 221
15.8 RESEARCH LIMITATIONS 221
16 APPENDIX 222
16.1 DISCUSSION GUIDE 222
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
16.3 CUSTOMIZATION OPTIONS 227
16.4 RELATED REPORTS 227
16.5 AUTHOR DETAILS 228

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD 25
TABLE 2 PHOTOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 48
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 51
TABLE 4 AVERAGE SELLING PRICE TREND OF PHOTOTHERAPY PRODUCTS,
BY KEY PLAYER 2025 (USD) 58
TABLE 5 AVERAGE PRICING TREND OF PHOTOTHERAPY PRODUCTS, BY REGION,
2024–2026 (USD) 58
TABLE 6 IMPORT DATA FOR PHOTOTHERAPY EQUIPMENT PRODUCTS UNDER HS CODE 9018090, BY COUNTRY, 2021–2025 (USD THOUSAND) 59
TABLE 7 EXPORT DATA FOR PHOTOTHERAPY EQUIPMENT UNDER HS CODE 903180,
BY COUNTRY, 2020–2024 (USD THOUSAND) 60
TABLE 8 PHOTOTHERAPY EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES
AND EVENTS (2026-2027) 60
TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 64
TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PHOTOTHERAPY EQUIPMENT 65
TABLE 11 TOP USE CASES AND MARKET POTENTIAL 74
TABLE 12 PHOTOTHERAPY EQUIPMENT MARKET: CASE STUDIES RELATED
TO AI IMPLEMENTATION 75
TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 76
TABLE 14 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF
PHOTOTHERAPY EQUIPMENT 79
TABLE 15 KEY BUYING CRITERIA FOR PHOTOTHERAPY EQUIPMENT 80
TABLE 16 PHOTOTHERAPY EQUIPMENT MARKET: UNMET NEEDS/END-USER EXPECTATIONS 81
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 21 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 22 GLOBAL STANDARDS IN PHOTOTHERAPY EQUIPMENT MARKET 85
TABLE 23 PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 87
TABLE 24 CONVENTIONAL PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 88
TABLE 25 CONVENTIONAL PHOTOTHERAPY EQUIPMENT MARKET VOLUME,
BY REGION, 2024–2031 (UNITS) 88
TABLE 26 FIBER-OPTIC PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 90
TABLE 27 FIBER-OPTIC PHOTOTHERAPY EQUIPMENT MARKET VOLUME, BY REGION,
2024–2031 (UNITS) 91
TABLE 28 PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 93
TABLE 29 PHOTOTHERAPY EQUIPMENT MARKET FOR NEONATAL JAUNDICE, BY COUNTRY, 2024–2031 (USD MILLION) 94
TABLE 30 PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE,
2024–2031 (USD MILLION) 95
TABLE 31 PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY COUNTRY,
2024–2031 (USD MILLION) 95
TABLE 32 PHOTOTHERAPY EQUIPMENT MARKET FOR PSORIASIS, BY COUNTRY,
2024–2031 (USD MILLION) 97
TABLE 33 PHOTOTHERAPY EQUIPMENT MARKET FOR VITILIGO, BY COUNTRY,
2024–2031 (USD MILLION) 99
TABLE 34 PHOTOTHERAPY EQUIPMENT MARKET FOR ECZEMA, BY COUNTRY,
2024–2031 (USD MILLION) 100
TABLE 35 PHOTOTHERAPY EQUIPMENT MARKET BY END USER, 2024–2031 (USD MILLION) 102
TABLE 36 PHOTOTHERAPY EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 103
TABLE 37 PHOTOTHERAPY EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 104
TABLE 38 PHOTOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 106
TABLE 39 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 107
TABLE 40 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 108
TABLE 41 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 108
TABLE 42 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 108
TABLE 43 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 109
TABLE 44 US: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 110
TABLE 45 US: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 110
TABLE 46 US: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 47 US: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 111
TABLE 48 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 112
TABLE 49 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 112
TABLE 50 CANADA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 112
TABLE 51 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 113
TABLE 52 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 113
TABLE 53 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 114
TABLE 54 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 114
TABLE 55 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 114
TABLE 56 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 115
TABLE 57 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 116
TABLE 58 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 116
TABLE 59 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 116
TABLE 60 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 117
TABLE 61 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 118
TABLE 62 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 118
TABLE 63 UK: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE,
2024–2031 (USD MILLION) 118
TABLE 64 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 119
TABLE 65 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 120
TABLE 66 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 120
TABLE 67 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 68 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 121
TABLE 69 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 122
TABLE 70 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 122
TABLE 71 ITALY: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 122
TABLE 72 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 123
TABLE 73 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 124
TABLE 74 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 124
TABLE 75 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 124
TABLE 76 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 125
TABLE 77 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 126
TABLE 78 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 126
TABLE 79 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 126
TABLE 80 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 127
TABLE 81 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 82 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 128
TABLE 83 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 129
TABLE 84 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 129
TABLE 85 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 129
TABLE 86 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 130
TABLE 87 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 130
TABLE 88 CHINA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 89 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 131
TABLE 90 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 132
TABLE 91 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 132
TABLE 92 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 132
TABLE 93 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 133
TABLE 94 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 134
TABLE 95 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 134
TABLE 96 INDIA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 134
TABLE 97 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 135
TABLE 98 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 136
TABLE 99 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 136
TABLE 100 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 136
TABLE 101 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 137
TABLE 102 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 138
TABLE 103 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 138
TABLE 104 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 105 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 139
TABLE 106 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 140
TABLE 107 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 140
TABLE 108 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 109 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET,
BY END USER, 2024–2031 (USD MILLION) 141
TABLE 110 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 111 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 142
TABLE 112 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 142
TABLE 113 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 114 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 143
TABLE 115 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 144
TABLE 116 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 144
TABLE 117 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 118 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 145
TABLE 119 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 146
TABLE 120 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 146
TABLE 121 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 146
TABLE 122 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 147
TABLE 123 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 147
TABLE 124 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 148
TABLE 125 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET
FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 126 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY END USER, 2024–2031 (USD MILLION) 148
TABLE 127 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY PRODUCT, 2024–2031 (USD MILLION) 149
TABLE 128 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 149
TABLE 129 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET
FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 150
TABLE 130 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET,
BY END USER, 2024–2031 (USD MILLION) 150
TABLE 131 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 151
TABLE 132 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 151
TABLE 133 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES,
BY TYPE, 2024–2031 (USD MILLION) 151
TABLE 134 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET,
BY END USER, 2024–2031 (USD MILLION) 152
TABLE 135 KEY DEVELOPMENTS IN PHOTOTHERAPY EQUIPMENT MARKET,
JANUARY 2021–MAY 2026 153
TABLE 136 PHOTOTHERAPY EQUIPMENT MARKET: DEGREE OF COMPETITION 156
TABLE 137 PHOTOTHERAPY EQUIPMENT MARKET: REGION FOOTPRINT 160
TABLE 138 PHOTOTHERAPY EQUIPMENT MARKET: PRODUCT FOOTPRINT 160
TABLE 139 PHOTOTHERAPY EQUIPMENT MARKET: APPLICATION FOOTPRINT 161
TABLE 140 PHOTOTHERAPY EQUIPMENT MARKET: END-USER FOOTPRINT 161
TABLE 141 PHOTOTHERAPY EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 164
TABLE 142 PHOTOTHERAPY EQUIPMENT MARKET: COMPETITIVE
BENCHMARKING OF STARTUPS/SMES 165
TABLE 143 PHOTOTHERAPY EQUIPMENT MARKET: PRODUCT LAUNCHES &
APPROVALS, JANUARY 2021–JANUARY 2026 168
TABLE 144 PHOTOTHERAPY EQUIPMENT MARKET: DEALS, JANUARY 2021–JANUARY 2026 169
TABLE 145 GE HEALTHCARE: COMPANY OVERVIEW 171
TABLE 146 GE HEALTHCARE: PRODUCTS OFFERED 172
TABLE 147 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 174
TABLE 148 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 175
TABLE 149 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–MAY 2026 176
TABLE 150 NATUS SENSORY: COMPANY OVERVIEW 177
TABLE 151 NATUS SENSORY: PRODUCTS OFFERED 177
TABLE 152 NATUS SENSORY: DEALS, JANUARY 2021–MAY 2026 178
TABLE 153 PHOTHERA: COMPANY OVERVIEW 180
TABLE 154 PHOTHERA: PRODUCTS OFFERED 180
TABLE 155 PHOTHERA: PRODUCT LAUNCHES, JANUARY 2021–MAY 2026 182
TABLE 156 SHANGHAI SIGMA HIGH-TECH CO., LTD.: COMPANY OVERVIEW 184
TABLE 157 SHANGHAI SIGMA HIGH-TECH CO., LTD.: PRODUCTS OFFERED 184
TABLE 158 SHANGHAI SIGMA HIGH-TECH CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2021–MAY 2026 185
TABLE 159 ATOM MEDICAL CORP: COMPANY OVERVIEW 188
TABLE 160 ATOM MEDICAL CORP: PRODUCTS OFFERED 188
TABLE 161 PHOENIX MEDICAL SYSTEMS: COMPANY OVERVIEW 189
TABLE 162 PHOENIX MEDICAL SYSTEMS: PRODUCTS OFFERED 189
TABLE 163 NEOLIGHT LLC: COMPANY OVERVIEW 190
TABLE 164 NEOLIGHT LLC: PRODUCTS OFFERED 190
TABLE 165 NEOLIGHT LLC: DEALS, JANUARY 2021–MAY 2026 191
TABLE 166 FANEM: COMPANY OVERVIEW 192
TABLE 167 FANEM: PRODUCTS OFFERED 193
TABLE 168 BISTOS CO., LTD.: COMPANY OVERVIEW 194
TABLE 169 BISTOS CO., LTD.: PRODUCTS OFFERED 194
TABLE 170 NINGBO DAVID MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW 195
TABLE 171 STRATA SKIN SCIENCES: COMPANY OVERVIEW 196
TABLE 172 XUZHOU KERNEL MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 197
TABLE 173 ULTRALITE ENTERPRISES, INC.: COMPANY OVERVIEW 198
TABLE 174 HOENLE MEDICAL GMBH COMPANY OVERVIEW 199
TABLE 175 WEYER GMBH: COMPANY OVERVIEW 199
TABLE 176 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 200
TABLE 177 THERALIGHT, LLC: COMPANY OVERVIEW 201
TABLE 178 ATHRODAX LTD: COMPANY OVERVIEW 202
TABLE 179 CURELIGHT: COMPANY OVERVIEW 203
TABLE 180 PHOTO THERAPEUTICS LTD: COMPANY OVERVIEW 204
TABLE 181 TINY HEARTS TECHNOLOGY: COMPANY OVERVIEW 205
TABLE 182 LIFETRONS INNO EQUIPMENTS PVT LTD: COMPANY OVERVIEW 205
TABLE 183 IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT LTD: COMPANY OVERVIEW 206
TABLE 184 SCI HEALTH: COMPANY OVERVIEW 207
TABLE 185 RISK ASSESSMENT: PHOTOTHERAPY EQUIPMENT 221

LIST OF FIGURES

FIGURE 1 PHOTOTHERAPY EQUIPMENT MARKET SEGMENTATION 24
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 27
FIGURE 3 PHOTOTHERAPY EQUIPMENT MARKET, 2026–2031 28
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN
PHOTOTHERAPY EQUIPMENT MARKET 29
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF
PHOTOTHERAPY EQUIPMENT MARKET 30
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHOTOTHERAPY EQUIPMENT MARKET, 2025 31
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 32
FIGURE 8 INCREASING ADOPTION OF ENERGY-EFFICIENT LED PHOTOTHERAPY SYSTEMS AND EXPANSION OF HOME-BASED TREATMENT SOLUTIONS TO DRIVE MARKET 33
FIGURE 9 CHINA AND CONVENTIONAL PHOTOTHERAPY EQUIPMENT
ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 34
FIGURE 10 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35
FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 35
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 36
FIGURE 13 PHOTOTHERAPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 37
FIGURE 14 PHOTOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 49
FIGURE 15 PHOTOTHERAPY EQUIPMENTS MARKET: SUPPLY CHAIN ANALYSIS 54
FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 56
FIGURE 17 PHOTOTHERAPY EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 18 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES IN PHOTOTHERAPY EQUIPMENT MARKET 62
FIGURE 19 PHOTOTHERAPY EQUIPMENT MARKET: INVESTMENT & FUNDING SCENARIO 62
FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2016–MAY 2026) 71
FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR PHOTOTHERAPY EQUIPMENT
(JANUARY 2016− MAY 2026) 72
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF
PHOTOTHERAPY EQUIPMENT 79
FIGURE 23 KEY BUYING CRITERIA FOR PHOTOTHERAPY EQUIPMENT 79
FIGURE 24 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET SNAPSHOT 107
FIGURE 25 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET SNAPSHOT 127
FIGURE 26 REVENUE ANALYSIS OF TOP PLAYERS IN PHOTOTHERAPY EQUIPMENT MARKET, 2021–2025 (USD MILLION) 155
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 156
FIGURE 28 PHOTOTHERAPY EQUIPMENTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 158
FIGURE 29 PHOTOTHERAPY EQUIPMENT MARKET: COMPANY FOOTPRINT 159
FIGURE 30 PHOTOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 163
FIGURE 31 EV/EBITDA OF KEY VENDORS 166
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 166
FIGURE 33 PHOTOTHERAPY EQUIPMENT MARKET: BRAND COMPARISON 167
FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT 172
FIGURE 35 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT 175
FIGURE 36 RESEARCH DESIGN 208
FIGURE 37 PRIMARY SOURCES 210
FIGURE 38 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS 212
FIGURE 39 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 213
FIGURE 40 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 213
FIGURE 41 REVENUE SHARE ANALYSIS ILLUSTRATION: GE HEALTHCARE 215
FIGURE 42 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2025) 215
FIGURE 43 PHOTOTHERAPY EQUIPMENT MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2031) 217
FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 218
FIGURE 45 DATA TRIANGULATION METHODOLOGY 219

---

---